Ikaria Bioscience Pty Ltd
4 clinical trials · Sponsor
◉ Watch Ikaria Bioscience Pty Ltd
| Record | Firm | Date |
|---|---|---|
| Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers (NCT07347678) | Ikaria Bioscience Pty Ltd | 2026-03-12 |
| Phase 1/2a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effect on Body Weight of RN3161 as Monotherapy and in Combination With Tirzepatide in Adults With Overweight and Obesity (NCT07245771) | Ikaria Bioscience Pty Ltd | 2025-11-04 |
| Study of RN0361in Adult Healthy Subjects and Adult Hypertriglyceridemic Subjects (NCT06471543) | Ikaria Bioscience Pty Ltd | 2024-09-30 |
| Adult Subjects With Elevated Low-Density Lipoprotein-Cholesterol to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects (NCT05905068) | Ikaria Bioscience Pty Ltd | 2023-07-14 |
Track Ikaria Bioscience Pty Ltd automatically
Every clearance here is in the API, with alerts when new ones post.